NGNE
Price
$15.06
Change
-$0.38 (-2.46%)
Updated
Apr 24, 02:38 PM (EDT)
Capitalization
197.24M
ZNTL
Price
$1.47
Change
-$0.03 (-2.00%)
Updated
Apr 24, 02:55 PM (EDT)
Capitalization
105.56M
13 days until earnings call
Ad is loading...

NGNE vs ZNTL

Header iconNGNE vs ZNTL Comparison
Open Charts NGNE vs ZNTLBanner chart's image
Neurogene
Price$15.06
Change-$0.38 (-2.46%)
Volume$400
Capitalization197.24M
Zentalis Pharmaceuticals
Price$1.47
Change-$0.03 (-2.00%)
Volume$101
Capitalization105.56M
NGNE vs ZNTL Comparison Chart
Loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NGNE vs. ZNTL commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Buy and ZNTL is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (NGNE: $15.46 vs. ZNTL: $1.50)
Brand notoriety: NGNE and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 119% vs. ZNTL: 93%
Market capitalization -- NGNE: $197.24M vs. ZNTL: $105.56M
NGNE [@Biotechnology] is valued at $197.24M. ZNTL’s [@Biotechnology] market capitalization is $105.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGNE’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • NGNE’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, ZNTL is a better buy in the long-term than NGNE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 5 TA indicator(s) are bullish while ZNTL’s TA Score has 4 bullish TA indicator(s).

  • NGNE’s TA Score: 5 bullish, 4 bearish.
  • ZNTL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NGNE is a better buy in the short-term than ZNTL.

Price Growth

NGNE (@Biotechnology) experienced а +43.55% price change this week, while ZNTL (@Biotechnology) price change was +18.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

NGNE is expected to report earnings on Nov 14, 2023.

ZNTL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($197M) has a higher market cap than ZNTL($106M). NGNE YTD gains are higher at: -32.371 vs. ZNTL (-50.660). NGNE has higher annual earnings (EBITDA): -49.96M vs. ZNTL (-207.96M). ZNTL has more cash in the bank: 391M vs. NGNE (139M). NGNE has less debt than ZNTL: NGNE (14.5M) vs ZNTL (40.5M). ZNTL has higher revenues than NGNE: ZNTL (40.6M) vs NGNE (925K).
NGNEZNTLNGNE / ZNTL
Capitalization197M106M186%
EBITDA-49.96M-207.96M24%
Gain YTD-32.371-50.66064%
P/E RatioN/AN/A-
Revenue925K40.6M2%
Total Cash139M391M36%
Total Debt14.5M40.5M36%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NGNEZNTL
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
NGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZNTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BYDDY100.722.52
+2.57%
BYD Co., Ltd.
SWRAY8.320.08
+0.97%
Swire Pacific Ltd.
TWOUQ0.27N/A
N/A
2U, Inc.
VWDRY4.30-0.11
-2.49%
Vestas Wind Systems A/S
OCANF3.60-0.10
-2.73%
Oceanagold Corp.

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+11.79%
BRNS - NGNE
51%
Loosely correlated
+8.02%
RNAZ - NGNE
48%
Loosely correlated
+1.96%
SNDX - NGNE
48%
Loosely correlated
+0.62%
ZNTL - NGNE
45%
Loosely correlated
+1.70%
MNMD - NGNE
44%
Loosely correlated
+5.00%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+1.70%
MDGL - ZNTL
51%
Loosely correlated
+2.01%
NGNE - ZNTL
45%
Loosely correlated
+11.79%
ORMP - ZNTL
43%
Loosely correlated
+0.66%
CRBU - ZNTL
41%
Loosely correlated
+0.79%
NRIX - ZNTL
40%
Loosely correlated
+1.31%
More